Subscribe to Newsletter

Joan Miller

The Power List 2014

Joan Miller

A pioneer of photodynamic therapy using verteporfin, which was the first pharmacotherapy for wet AMD, Joan Miller also helped to define the importance of VEGF in intraocular vascular disease. Today she continues to investigate the molecular pathophysiology of vision loss and to develop improved therapies for retinal disease.

Part of the Power List 2014

The 100 most influential people

Who are the 100 most influential people in ophthalmology?
That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2014

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: